找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: FDA Bioequivalence Standards; Lawrence X. Yu,Bing V. Li Book 2014 The United States Government 2014 ANDA.bioequivalence.narrow therapeutic

[复制链接]
查看: 49702|回复: 56
发表于 2025-3-21 19:49:40 | 显示全部楼层 |阅读模式
书目名称FDA Bioequivalence Standards
编辑Lawrence X. Yu,Bing V. Li
视频videohttp://file.papertrans.cn/341/340036/340036.mp4
概述Covers the fundamentals as well as the most up-to-date progress in bioequivalence standards, which are critical to new and generic development and regulation.Discusses the current best practices in bi
丛书名称AAPS Advances in the Pharmaceutical Sciences Series
图书封面Titlebook: FDA Bioequivalence Standards;  Lawrence X. Yu,Bing V. Li Book 2014 The United States Government 2014 ANDA.bioequivalence.narrow therapeutic
描述.This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products..FDA Bioequivalence Standards. is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters.. .The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as under
出版日期Book 2014
关键词ANDA; bioequivalence; narrow therapeutic window index drugs; regulations; simulation
版次1
doihttps://doi.org/10.1007/978-1-4939-1252-0
isbn_softcover978-1-4939-5558-9
isbn_ebook978-1-4939-1252-0Series ISSN 2210-7371 Series E-ISSN 2210-738X
issn_series 2210-7371
copyrightThe United States Government 2014
The information of publication is updating

书目名称FDA Bioequivalence Standards影响因子(影响力)




书目名称FDA Bioequivalence Standards影响因子(影响力)学科排名




书目名称FDA Bioequivalence Standards网络公开度




书目名称FDA Bioequivalence Standards网络公开度学科排名




书目名称FDA Bioequivalence Standards被引频次




书目名称FDA Bioequivalence Standards被引频次学科排名




书目名称FDA Bioequivalence Standards年度引用




书目名称FDA Bioequivalence Standards年度引用学科排名




书目名称FDA Bioequivalence Standards读者反馈




书目名称FDA Bioequivalence Standards读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:25:23 | 显示全部楼层
第140036主题贴--第2楼 (沙发)
发表于 2025-3-22 03:22:45 | 显示全部楼层
板凳
发表于 2025-3-22 05:06:08 | 显示全部楼层
第4楼
发表于 2025-3-22 10:00:03 | 显示全部楼层
5楼
发表于 2025-3-22 16:21:11 | 显示全部楼层
6楼
发表于 2025-3-22 20:51:38 | 显示全部楼层
7楼
发表于 2025-3-22 22:22:53 | 显示全部楼层
8楼
发表于 2025-3-23 04:16:09 | 显示全部楼层
9楼
发表于 2025-3-23 08:48:57 | 显示全部楼层
10楼
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-9-12 00:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表